Thu, Oct 17 3:51am


AERI $20.77 0.49 (2.42%)
Aerie Pharmaceuticals Inc
NASDAQ: AERI $1,030 Million Small-Cap. Drug Manufacturers industry. 5 Year Return 5%. 1 Year Return 64%. 2019 YTD Return 43%. Negative 5 year, 1 year & YTD returns. You may want to avoid this one until things turn around. Check out some Uptrending symbols instead. Earnings in 19 days on Tue, Nov 5. (Use the Earnings tab below to add this date to your calendar.)

AERI Profile

Market Cap 1 Billion
AERI Description

Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on discovery, development, and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Its main products are Rhopressa and Roclatan. The company mainly operates in North America.

Visit Website

AERI Earnings

EPS -1.04 P/E Ratio 0.00
Previous Wed, Aug 7, 2019
Latest Tue, Nov 5, 2019 (In 19 days)

AERI Dividend

Yield --
Ex-Date --
Pay Date --
History --

AERI Charts

52 Week Low $17.51 set on Thu, Oct 10, 2019
1 Year
Oct 10, 2019
Oct 17, 2018

Symbol Price Day Ξ” YTD Ξ”
AERI $20.77 2.42% -42.81%


Symbol Surfing

How can we make Symbol Surfing better?

©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy | Terms Of Service | Privacy Policy